Rhythm Pharmaceuticals (NASDAQ: RYTM) faced a significant downgrade from Zacks Research, moving from a “hold” rating to a “strong sell” rating, as reported on Monday. This...
Shares of Option Care Health (NASDAQ: OPCH) received an upgrade from Wall Street Zen, which changed its rating from hold to buy. This announcement came in...
On August 16, 2023, Citizens Jmp began coverage of Assembly Biosciences (NASDAQ: ASMB), assigning an “outperform” rating along with a target price of $38.00. This biopharmaceutical...
